Navigation Links
Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis)
Date:10/20/2010

mpanies, has introduced Pirfenidone in India under the brand name Pirfenex, for the treatment of IPF. A chronic progressive form of lung disease, IPF has average survival rates as low as 3-5 years which is less than many cancers. Till now there is no approved treatment for IPF. Pirfenidone is a novel anti-fibrotic drug which through clinical trials has shown to slow down progression of this terminal disease and stabilize lung function.

Cipla's technical prowess along with leadership in terms of range of drugs and therapeutic categories in the respiratory segment, is leading the fight to provide world class affordable treatment for patients with orphan diseases. Commenting on the launch, Dr. J Gogtay, Medical Director, Cipla, said, "The launch of Pirfenex is a significant step forward. With increased availability and affordability, Pirfenex could now offer hope to those afflicted with this condition."

Pirfenex will be manufactured at Cipla's state-of-the-art manufacturing facility at Himachal Pradesh, India which is approved by WHO, MCC -South Africa and TGA - Australia.

In addition to the launch, Cipla will host and disseminate a series of lectures on IPF to physicians in India and across the world. Addressing the delegates Prof Luca Richeldi, Director, Center for Rare Lung Diseases, University of Modena and Reggio Emilia, Italy, said, "Patients affected by IPF have a distinctively poor prognosis, and until now no drugs have been approved to treat IPF. Pirfenidone represents the first concrete chance of slowing down disease progression. The effect on increasing progression free survival, as showed in three combined studies, coupled with an acceptable safety profile, opens up a new path for better management of IPF."

Last year Cipla launched the world's first generic Bosentan, for the treatment of Pulmonary Arterial Hypertension. With the launch of Pirfenex, Cipla reaffirms its leadership in the respira
'/>"/>

SOURCE Cipla Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Frost & Sullivan Award Underlines Cipla Medpros Status as Company of the Year in the South African Generic Pharmaceutical Market
2. Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training
3. Brazoria County Launches Free Prescription Discount Card
4. BioMolecular Therapeutics, a New Global Player in RNAi Therapeutics, Launches Company and Adds Key Advisors
5. endpoint Launches PULSE 2.0 Allowing Clinical Research Teams to Save Additional Time and Money By Rapidly Deploying Studies With Custom Reporting
6. Aircraft Medical Launches Worlds First Low Cost Video Laryngoscope
7. Cantel Medical Corp. Launches New Medical Face Mask Addressing Issue of Fit
8. New England Biolabs Launches a Suite of Innovative Tools to Advance Epigenetics Research, Including PCR-Based Assay to Identify and Quantitate 5-hmC in Epigenome
9. International Medical News Group Relaunches Internal Medicine News Digital Network and Hospitalist News Digital Network
10. Physicians Interactive Launches Partnership with SampleMD to Expand Sampling Options for Clinicians and Reduce Costs for Patients
11. Terso Solutions Launches New RFID-Enabled Freezer for Inventory Management in Hospitals, Research Labs, Manufacturers and Distributors, and Crime Labs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Holdings, Inc. (NYSE and SIX: ZMH) is celebrating a key milestone in ... Knee System. ,   ... introduced the NexGen knee system, with its innovative design and ... of the NexGen knee have taken place worldwide. ... the importance of design innovation and component quality for surgeons and patients ...
(Date:3/27/2015)... 27, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... its previously announced registered offering of common shares in ... Pursuant to the Offering, the Company issued 7,286,432 common ... aggregate gross proceeds of approximately $1.45 billion. On March ... and Exchange Commission a final prospectus supplement to its ...
(Date:3/27/2015)... MARLBOROUGH, Mass. , March 27, 2015 ... ) and privately-held MirImmune LLC, today announced ... license agreement to RXi,s novel and proprietary ... cell-based cancer immunotherapies. The collaboration has the ... and patient friendly cancer treatments that could ...
Breaking Medicine Technology:Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5
... Fla., Sept. 27, 2011 Nuance Health today announced ... conducted on their innovative product, Swype Cold & Flu ... The clinical study, conducted on 103 volunteers ... the effectiveness, tolerability, and willingness of participants to use ...
... China, Sept. 27, 2011 /PRNewswire-Asia/ -- China Health Resource, ... Chinese Medicine (TCM) products, announced robust quarterly earnings for ... and $1.7 million in net income, 443% increase from ... of about $0.02 per share for the first half ...
Cached Medicine Technology:Swype Cold & Flu Shield Significantly Reduces Occurrence of Colds in Clinical Study 2China Health Resource, Inc. Announces Record 2nd Quarter 2011 Results 2China Health Resource, Inc. Announces Record 2nd Quarter 2011 Results 3
(Date:3/29/2015)... Elfster.com, the top-rated Secret Santa generator, is proud ... publicize its gift exchange generator technology and extend its ... leader in Secret Santa online gift exchanges, the company ... see the opportunities as well. , "We are very ... CEO of Elster.com. "With Christmas and Valentine’s behind us, ...
(Date:3/29/2015)... The culmination of one of the most ... Final Four invades Lucas Oil Stadium in Indianapolis ... filled with excitement, buzzer-beaters, and of course, upsets. Throughout the ... been made, and future professional products have been seen. In ... four teams that advanced through their regional bracket with the ...
(Date:3/29/2015)... PORTLAND, Ore. (PRWEB) March 29, 2015 ... and Marion counties in Oregon to assess the feasibility ... youth with emotional and behavioral problems and their families. ... competition to select participants that will be provided technical ... The Oregon counties join six other national awardees chosen ...
(Date:3/28/2015)... Coffee could not only perk you up in the morning ... have found. , They found that those who drank coffee ... fight gum disease. Does coffee, then, help fight gum disease? ... Goldman School of Dental Medicine explored in a study ... of Periodontology. , “This is the first long-term study of ...
(Date:3/28/2015)... York, New York (PRWEB) March 28, 2015 ... http://www.vaginalmeshlawsuit2015.com/ ) involving devices manufactured by C.R. Bard, ... litigation underway in U.S. District Court, Southern District ... S. Grand, is serving on the Plaintiffs’ Steering ... 24th, the Court has granted certain defendants named ...
Breaking Medicine News(10 mins):Health News:Gift Exchange Generator Promotion Achieves Early Success, Announces Elfster 2Health News:Cheap 2015 Final Four Tickets: Ticket Down Slashes Kentucky Wildcats and Wisconsin Badgers Final Four Tickets at Lucas Oil Stadium and Issues Valuable Promo Code 2Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 2Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 3Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 4Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4
... Scientists may have a way to make the ... more effective against some cancers. The chemotherapeutic agent used in ... in kidney damage or failure in about 30 percent of ... can do today to protect the kidneys is advise patients ...
... -- A man,s heart disease risk after the age of 40 ... size and placenta size when he was born, a new study ... nutrition and the early growth of her child," study lead author ... of Southampton in the United Kingdom, said in a news release ...
... Clinical Cardiology reveals that in men with ... libido, erectile dysfunction, and sexual performance. Chronic heart failure ... fatigue and exercise intolerance. HF patients experience decreased libido ... of pacemaker that paces the right and left ventricle, ...
... RIVERSIDE, Calif. Physicians can help their patients ... particularly in chronic disease management by using ... researchers from the University of California, Riverside, Texas ... Riverside, Calif. The Information-Motivation-Strategy (IMS) Model ...
... the University of Southern California have pinned down the ... trait: our ability to comprehend a sceneeven one never ... The key is to process the interacting objects that ... to corresponding author Irving Biederman, professor of psychology and ...
... -- Newly diagnosed cancer patients frequently face hurdles in ... to new research from the Perelman School of Medicine ... Saturday, June 4 at the 2011 annual meeting of ... with private health insurance had difficulty scheduling an appointment, ...
Cached Medicine News:Health News:Cause and potential treatment found for cancer drug's kidney toxicity 2Health News:Male Heart Disease May Be Linked to Mom's Lifetime Nutrition 2Health News:Researchers develop strategy to improve patient adherence 2Health News:Researchers develop strategy to improve patient adherence 3Health News:USC study locates the source of key brain function 2Health News:Two-thirds of newly diagnosed cancer patients unable to obtain oncology appointments 2
... is especially designed for the atraumatic removal ... sleek design of this probe minimizes the ... Due to its 24K gold plating, the ... foreign body incarceration. The magnetic probe is ...
... flexible continuous monitoring, the M3 and M4 ... and neonatal patient care. M Series monitors ... includes a basic set of non-invasive parameters ... Optional Multi-Measurement Server extensions offer Mainstream or ...
... the patients side and in transit., ... measurements in a compact package to match ... care, lower acuity environments, and patient transfer., ... patient monitoring, the IntelliVue MP20 Junior has ...
... High-performance monitoring for flexible care settings., ... monitors combine portability and measurement flexibility ... needs of intermediate care environmentsat the ... strong heritage in patient monitoring, IntelliVue ...
Medicine Products: